Inovio Pharmaceuticals, Inc.

NASDAQ: INO
$19.73
-$7.22 (-26.8%)
Closing price July 1, 2020
While COVID-19 pandemic is not its only target, that has been the main driver of the interest in Inovio Pharmaceuticals so far in 2020.
Friday's top analyst upgrades and downgrades included Amazon.com, Broadcom, Boeing, DraftKings, eBay, Electronic Arts, Hilton Worldwide, iRobot, NetApp, Peloton Interactive and Tesla.
Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.
Thursday's top analyst upgrades and downgrades included Aerojet Rocketdyne, Avis Budget, Carnival, Chipotle Mexican Grill, Expedia, Home Depot, Lowe's, MGM Resorts, Stratasys, Square and Walmart.
Wednesday's top analyst upgrades and downgrades included Alphabet, Advanced Micro Devices, Corning, FireEye, Inovia Pharmaceuticals, Lululemon Athletica, Nike, Roku, Starbucks, Tyson Foods and...
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Thursday’s big drop because they have some aspect of their business that might be immune to daily scares or...
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Monday's big drop because they have some aspect of their business that might be immune to daily scares or...
These stocks that are either defensive in general or are defying the big drop because they have some aspect of their business that might be immune to daily scares or because they are potential...
Day two of the coronavirus scare is now in the books and practically all major American averages are down over 3% for their second consecutive day. Currently all the gains for the year for each of...
The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a handful of stocks were acting as a natural hedge to the virus news.